Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In the SURMOUNT-5 head-to-head trial, tirzepatide produced 20.2% average weight loss versus 13.7% for semaglutide
With the right balance, you can cut unwanted fat, keep your muscle, and build a solid foundation for results that last
After one year and four months, the average weight loss experienced by participants was 33.7 pounds, with the majority of weight loss occurring among those taking semaglutide
Retatrutides Phase 2 data, while impressive, involved a smaller participant sample than CagriSemas Phase 3 program
Peptides emerge as the latest weight loss trend Peptides are the latest buzzy trend to take over the weight loss and fitness world, following the surge in popularity of GLP-1 medications such as Wegovy and Ozempic
Market pricing provides another crucial filter
US$ 20.56
US$ 21.99
US$ 22.96
US$ 23.05
US$ 26.11
US$ 22.12
